ESC Premium Access

Therapeutic modulation of the immune response in atherosclerosis

Event: ESC CONGRESS 2016
Topic: Atherosclerosis
Session type: Advances in Science
Date: 30 August 2016
Time: 08:30 - 10:00

Congress Session

5 presentations in this session

State of the art in therapeutic modulation of the immune response in atherosclerosis

Speaker: Professor P. Libby (Boston, US)

Nanoparticle-enabled RNAi in endothelial cells attenuates inflammation in atherosclerosis and acute myocardial infarction

Speaker: Doctor H. Sager (Munich, DE)

STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells

Speaker: Doctor L. Xu (Shanghai, CN)

Bone marrow-specific Sirt6 deletion enhances atherosclerosis and foam cell formation via an increase in macrophage scavenger receptor 1 expression

Speaker: Miss T. Arsiwala (Zurich, CH)

Future direction for research in therapeutic modulation of the immune response in atherosclerosis.

Speaker: Professor J. Nilsson (Malm?, SE)

5 speakers from this session

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
32 presentations

Doctor Hendrik Sager

German Heart Center of Munich, Munich (Germany)
2 presentations
0 follower

Doctor Lili Xu

Zhongshan Hospital, Fudan University, Shanghai (China)
0 follower

Miss Tasneem Arsiwala

University of Zurich, Zurich (Switzerland)
0 follower

Professor Jan Nilsson

Department of Clinical Sciences Malm?, Malm? (Sweden)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk